| Product NDC: | 0069-0080 |
| Proprietary Name: | Mitoxantrone Hydrochloride |
| Non Proprietary Name: | Mitoxantrone Hydrochloride |
| Active Ingredient(s): | 2 mg/mL & nbsp; Mitoxantrone Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0069-0080 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA201014 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121212 |
| Package NDC: | 0069-0080-01 |
| Package Description: | 10 mL in 1 VIAL (0069-0080-01) |
| NDC Code | 0069-0080-01 |
| Proprietary Name | Mitoxantrone Hydrochloride |
| Package Description | 10 mL in 1 VIAL (0069-0080-01) |
| Product NDC | 0069-0080 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mitoxantrone Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20121212 |
| Marketing Category Name | ANDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
| Substance Name | MITOXANTRONE HYDROCHLORIDE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |